EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research

the EuGMS Task and Finish Group on  Fall-Risk-Increasing Drugs, the EuGMS Special Interest Group on Pharmacology

Research output: Contribution to journalArticle

Abstract

Falls are a major public health concern in the older population, and certain medication classes are a significant risk factor for falls. However, knowledge is lacking among both physicians and older people, including caregivers, concerning the role of medication as a risk factor. In the present statement, the European Geriatric Medicine Society (EuGMS) Task and Finish group on fall-risk-increasing drugs (FRIDs), in collaboration with the EuGMS Special Interest group on Pharmacology and the European Union of Medical Specialists (UEMS) Geriatric Medicine Section, outlines its position regarding knowledge dissemination on medication-related falls in older people across Europe. The EuGMS Task and Finish group is developing educational materials to facilitate knowledge dissemination for healthcare professionals and older people. In addition, steps in primary prevention through judicious prescribing, deprescribing of FRIDs (withdrawal and dose reduction), and gaps in current research are outlined in this position paper.

Original languageEnglish
Pages (from-to)299-307
Number of pages9
JournalDrugs and Aging
Volume36
Issue number4
DOIs
Publication statusPublished - Apr 9 2019

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research'. Together they form a unique fingerprint.

  • Cite this

    the EuGMS Task and Finish Group on  Fall-Risk-Increasing Drugs, & the EuGMS Special Interest Group on Pharmacology (2019). EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research. Drugs and Aging, 36(4), 299-307. https://doi.org/10.1007/s40266-018-0622-7